A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia
Clinical trial NCT07038876 · COMPLETED
Trial details
- NCT number
- NCT07038876
- Sponsor
- MapLight Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-27
- Primary completion
- 2026-06-04
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.